Login / Signup

Severe immune-related complications early after allogeneic hematopoietic cell transplantation for nivolumab-pretreated lymphoma.

Masatomo KunoAyumu ItoTakashi TanakaYoshihiro InamotoSaiko KurosawaSung-Won KimTakahiro Fukuda
Published in: Bone marrow transplantation (2018)
Keyphrases
  • stem cell transplantation
  • bone marrow
  • diffuse large b cell lymphoma
  • early onset
  • risk factors
  • hematopoietic stem cell
  • drug induced
  • high dose